Clovis Oncology (CLVS) Tops Q3 EPS by 25c

November 3, 2016 4:07 PM EDT
Get Alerts CLVS Hot Sheet
Trade CLVS Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Clovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($1.70), $0.25 better than the analyst estimate of ($1.95).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment